Shai Gozani - Feb 2, 2024 Form 4 Insider Report for NeuroMetrix, Inc. (NURO)

Role
President & CEO, Director
Signature
/s/ Thomas T. Higgins, Attorney-in-fact
Stock symbol
NURO
Transactions as of
Feb 2, 2024
Transactions value $
-$285
Form type
4
Date filed
3/6/2024, 05:23 PM
Previous filing
Mar 6, 2024
Next filing
Apr 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NURO Common Stock Options Exercise $1.93K +636 +6.44% $3.03 10.5K Feb 2, 2024 Direct F1
transaction NURO Common Stock Tax liability -$285 -94 -0.89% $3.03 10.4K Feb 2, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NURO Restricted Stock Unit Options Exercise -$1.93K -636 -16.68% $3.03 3.18K Feb 2, 2024 Common Stock 636 $3.03 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares earned upon the vesting of restricted stock units referenced in footnote 3.
F2 Represents shares withheld in payment of withholding taxes upon vesting of the restricted stock units referenced in footnote 3.
F3 On May 24,2022, the reporting person was granted 61,029 restricted stock units prior to the reverse stock split of the Issuer's common stock at a ratio of 1-for-8, effective as of November 21, 2023, which vest in equal quarterly installments over three years beginning on August 2, 2022.